Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-13 5:09 pm Purchase | 2026-01-09 | 13D | FOGHORN THERAPEUTICS INC FHTX | Flagship Ventures Fund V L.P. | 20,774,885 27.200% | 4,470,936 (+27.42%) | Filing History |
| 2024-12-31 5:37 pm Sale | 2024-12-29 | 13D | OMEGA THERAPEUTICS INC OMGAQ | Flagship Ventures Fund V L.P. | 29,225,579 52.800% | -19,852 (-0.07%) | Filing History |
| 2024-05-24 5:00 pm Purchase | 2024-05-22 | 13D | FOGHORN THERAPEUTICS INC FHTX | Flagship Ventures Fund V L.P. | 16,303,949 22.900% | 3,629,829 (+28.64%) | Filing History |
| 2024-02-14 4:36 pm Sale | 2023-12-31 | 13G | SIGILON THERAPEUTICS INC SGTX | Flagship Ventures Fund V L.P. | 0 0.000% | -797,721 (Position Closed) | Filing History |
| 2024-02-14 4:19 pm Sale | 2023-12-31 | 13G | SANA BIOTECHNOLOGY INC SANA | Flagship Ventures Fund V L.P. | 25,583,551 13.000% | -8,655,467 (-25.28%) | Filing History |
| 2023-07-13 5:00 pm Purchase | 2023-07-11 | 13D | EVELO BIOSCIENCES INC EVLO | Flagship Ventures Fund V L.P. | 7,932,624 42.200% | 5,411,258 (+214.62%) | Filing History |
| 2023-02-27 5:02 pm Purchase | 2023-02-22 | 13D | OMEGA THERAPEUTICS INC OMGAQ | Flagship Ventures Fund V L.P. | 29,245,431 53.200% | 3,343,162 (+12.91%) | Filing History |
| 2023-02-14 1:02 pm Purchase | 2022-12-31 | 13G | CODIAK BIOSCIENCES INC CDAKQ | Flagship Ventures Fund V L.P. | 4,473,969 11.800% | 1,866,666 (+71.59%) | Filing History |
| 2022-06-01 5:01 pm Purchase | 2022-05-27 | 13D | EVELO BIOSCIENCES INC EVLO | Flagship Ventures Fund V L.P. | 2,521,366 46.700% | 1,369,863 (+118.96%) | Filing History |
| 2022-02-14 3:02 pm Purchase | 2021-12-31 | 13G | SANA BIOTECHNOLOGY INC SANA | Flagship Ventures Fund V L.P. | 34,239,018 18.100% | 34,239,018 (New Position) | Filing History |
| 2021-08-05 6:43 pm Purchase | 2021-08-03 | 13D | OMEGA THERAPEUTICS INC OMGAQ | Flagship Ventures Fund V L.P. | 25,902,269 55.400% | 25,902,269 (New Position) | Filing History |